General Information of Drug Inactive Ingredient (DIG) (ID: E00149)

DIG Name
methylparaben
Synonyms
Methyl 4-hydroxybenzoate; METHYLPARABEN; 99-76-3; Methyl paraben; Methyl p-hydroxybenzoate; Nipagin; Methyl parahydroxybenzoate; Maseptol; p-Hydroxybenzoic acid methyl ester; p-Methoxycarbonylphenol; 4-Hydroxybenzoic acid methyl ester; Benzoic acid, 4-hydroxy-, methyl ester; p-Carbomethoxyphenol; Tegosept M; Methaben; Metoxyde; Preserval; Metaben; Moldex; Paridol; Septos; Solbrol; Methyl parasept; Methyl butex; Methyl chemosept; Nipagin M; Aseptoform; Methylben; Abiol; Methyl-p-hydroxybenzoate; Preserval M; Solbrol M; 4-(Methoxycarbonyl)phenol; Methyl p-oxybenzoate; 4-Hydroxybenzoic acid, methyl ester; Methyl ester of p-hydroxybenzoic acid; p-Oxybenzoesauremethylester; MFCD00002352; FEMA No. 2710; Benzoic acid, p-hydroxy-, methyl ester; UNII-A2I8C7HI9T; NSC 3827; p-Hydroxybenzoic acid, methyl ester; p-Hydroxybenzoic methyl ester; 4-HYDROXY-BENZOIC ACID METHYL ESTER; Methylester kyseliny p-hydroxybenzoove; A2I8C7HI9T; CHEMBL325372; CHEBI:31835; NCGC00159376-02; NCGC00159376-04; E218; DSSTox_CID_2529; WLN: QR DVO1; DSSTox_RID_76616; DSSTox_GSID_22529; Methyl 4-hydroxybenzoate, 99%; Caswell No. 573PP; FEMA Number 2710; CAS-99-76-3; SMR000036660; CCRIS 3946; HSDB 1184; p-Oxybenzoesauremethylester [German]; EINECS 202-785-7; methyl 4- hydroxybenzoate; Methylparaben [USAN:NF]; EPA Pesticide Chemical Code 061201; BRN 0509801; Metagin; METHYL4-HYDROXYBENZOATE; AI3-01336; Lexgard M; Paraben M; Methylester kyseliny p-hydroxybenzoove [Czech]; Methylparaben, NF; Methylparaben, FCC; 4-carbomethoxyphenol; Methylparaben (NF); Methylparaben (TN); INS number 218; Solparol (Salt/Mix); 4-hydroxymethylbenzoate; methyl 4-hydoxybenzoate; ACMC-20aiv0; methyl 4 hydroxybenzoate; methyl 4-hydroxylbenzoate; methyl 4-hydroxy-benzoate; methyl-4-hydroxy-benzoate; Methylis parahydroxybenzoas; Preserval MS (Salt/Mix); bmse010009; EC 202-785-7; methyl (4-hydroxy)benzoate; cid_7456; SCHEMBL4440; MLS001304047; MLS001304187; ARONIS27185; BIDD:ER0241; COC(=O)c1ccc([O])cc1; 4-hydroxybenzoate methyl ester; Methyl 4-Hydroxybenzoate,(S); INS No. 218; AMY901; GTPL6273; ZINC1712; Methyl parahydroxybenzoate (TN); RARECHEM AL BF 0098; DTXSID4022529; FEMA 2710; TIMTEC-BB SBB040908; 4-Hydroxybenzoic acid methylester; methyl 4-hydroxybenzenecarboxylate; NSC3827; OTAVA-BB 1310956; 4-Hydroxybenzoic acid-methyl ester; HMS2883I08; LABOTEST-BB LTBB002210; Methyl Paraben, analytical standard; Methyl parahydroxybenzoate (JP17); 4-hydroxy benzoic acid methyl ester; CS-D1181; HY-N0349; METHYL PARA HYDROXY BENZOATE; NSC-3827; AKOS BBS-00004393; Tox21_111616; Tox21_202318; Tox21_300009; ANW-75370; BBL005648; BDBM50209100; CK1194; NSC406127; s3985; SBB040908; STK802470; AKOS000119910; Tox21_111616_1; AS01626; CCG-266228; DB14212; MCULE-5368262482; NSC-406127; 4-HYDROXYBENZOIC ACID METYL ESTER; Methyl 4-hydroxybenzoate, >=99%, FCC; NCGC00159376-03; NCGC00159376-05; NCGC00159376-06; NCGC00253939-01; NCGC00259867-01; AK-54335; SY006626; BENZOIC ACID,4-HYDROXY,METHYL ESTER; DB-080628; 216-EP2269989A1; 216-EP2279750A1; 216-EP2287158A1; 216-EP2289879A1; 216-EP2289893A1; 216-EP2295426A1; 216-EP2295427A1; 216-EP2295439A1; 216-EP2305668A1; 216-EP2305673A1; 216-EP2308838A1; 216-EP2308877A1; 216-EP2311834A1; BB 0263150; E 218; FT-0618697; FT-0672044; M2206; Methyl 4-hydroxybenzoate, analytical standard; Methyl 4-hydroxybenzoate, p.a., 98-102%; ST50214511; (2,2-DIMETHYLDIOXALANE)METHYL BUTYRATE; D01400; M-6148; 62345-EP2272817A1; 62345-EP2281817A1; 62345-EP2308828A2; 62345-EP2308839A1; 62345-EP2371808A1; Methyl 4-hydroxybenzoate, USP, 98.0-102.0%; 108078-EP2272843A1; 108078-EP2281817A1; 108078-EP2287155A1; 108078-EP2295414A1; 108078-EP2298746A1; Q229987; Q-200479; Methyl 4-hydroxybenzoate, SAJ first grade, >=98.0%; Methyl 4-hydroxybenzoate, tested according to Ph.Eur.; Z19674820; F1908-0119; Methyl 4-hydroxybenzoate, BioXtra, >=99.0% (titration); Methylparaben, certified reference material, TraceCERT(R); UNII-AZF98361GV component LXCFILQKKLGQFO-UHFFFAOYSA-N; 4-Hydroxybenzoic acid-methyl ester 1000 microg/mL in Acetonitrile; Methyl 4-hydroxybenzoate, ReagentPlus(R), >=99.0%, crystalline; Methylparaben, United States Pharmacopeia (USP) Reference Standard; Methyl 4-hydroxybenzoate, BioReagent, suitable for insect cell culture; Methyl parahydroxybenzoate, European Pharmacopoeia (EP) Reference Standard; Methylparaben, Pharmaceutical Secondary Standard; Certified Reference Material
DIG Function
Antimicrobial preservative
Formula
C8H8O3
Canonical SMILES
COC(=O)C1=CC=C(C=C1)O
InChI
1S/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H3
InChIKey
LXCFILQKKLGQFO-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 152.15 Topological Polar Surface Area 46.5
XlogP 2 Complexity 136
Heavy Atom Count 11 Rotatable Bond Count 2
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 3

Full List of Drug(s) Co-administrated with This DIG

62 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Acetaminophen DMUIE76 Pain [MG30-MG3Z] Acetaminophen 500 mg tablet F00390
Adapalene DMX2358 Acne vulgaris [ED80] Adapalene 0.3% gel F24250
Amantadine DMS3YE9 Influenza A virus infection [1E30] Amantadine 100 mg capsule F00918
Amlexanox DM0DQM5 Respiratory tract inflammation [CA07] Amlexanox 2mg Patch F23625
Amoxicillin DMUYNEI Bacterial infection [1A00-1C4Z] Amoxicillin 250 mg capsule F01256
Aspirin DM672AH Myocardial infarction [BA41-BA43] Aspirin 325 mg tablet F01593
Benzonatate DM9U4FO Cough [MD12] Benzonatate 100 mg capsule F02350
Calcitriol DM8ZVJ7 Congenital alopecia [LC30] Calcitriol 0.0005 mg capsule F03163
Ceftibuten DMWV2AG Chronic bronchitis [CA20.1] Ceftibuten 400 mg capsule F03680
Chlordiazepoxide DMTN5XI Anxiety disorder [6B00-6B0Z] Chlordiazepoxide 10 mg capsule F03980
Chlorpheniramine DM5URA2 Allergic rhinitis [CA08.0] Chlorpheniramine 12 mg tablet F04018
Chlorpromazine DMBGZI3 Schizophrenia [6A20] Chlorpromazine 100 mg tablet F04057
Clofazimine DMEBOFW Crohn disease [DD70] Clofazimine 100mg capsule F23118
Clomipramine DMINRKW Depression [6A70-6A7Z] Clomipramine 25 mg capsule F04568
Cycloserine DMT1I52 Bacterial infection [1A00-1C4Z] Cycloserine 250 mg capsule F05160
Desonide DMTP2NJ Atopic dermatitis [EA80] Desonide 0.05% lotion F23703
Diazoxide DML1538 Hypertension [BA00-BA04] Diazoxide 1.5g/30ml suspension F23709
Diltiazem DMAI7ZV Hypertension [BA00-BA04] Diltiazem 120 mg tablet F05929
Diphenhydramine DMKQTBA Meniere disease [AB31.0] Diphenhydramine 25 mg capsule F06256
Dipyridamole DMXY30O Hypertension [BA00-BA04] Dipyridamole 25 mg tablet F06541
Disopyramide DM5SYZP Ventricular arrhythmias [BC71] Disopyramide 100 mg capsule F06572
Ergocalciferol DMHO0AR Hypoparathyroidism [5A50] Ergocalciferol 50000 unt capsule F07340
Ethosuximide DMDZ9LT Epilepsy [8A60-8A68] Ethosuximide 250 mg capsule F07706
Exemestane DM9HPW3 Hormonally-responsive breast cancer [2C60-2C65] Exemestane 25 mg tablet F07818
Flucytosine DM13VTW Endocarditis [BB40-BA42] Flucytosine 250 mg capsule F08398
Flumazenil DMPCG2L Benzodiazepine overdose [PC91] Flumazenil 1mg/10ml injectable F23744
Fluocinolone acetonide DMG2KI4 Inflammation [1A00-CA43.1] Fluocinolone Acetonide 0.01% ointment F23747
Fluorouracil DMUM7HZ Solid tumour/cancer [2A00-2F9Z] Fluorouracil 0.5% cream F23754
Fluoxetine DM3PD2C Depression [6A70-6A7Z] Fluoxetine 20 mg capsule F08473
Fluvastatin DM4MDJY Hypercholesterolaemia [5C80.0] Fluvastatin 20 mg capsule F08582
Gemfibrozil DMD8Q3J Hyperlipidaemia [5C80] Gemfibrozil 600 mg tablet F09081
Gentamicin DMKINJO Bacterial infection [1A00-1C4Z] Gentamicin 0.1% ointment F23760
Griseofulvin DMK54YG Ringworm infection [1F28] Griseofulvin 125 mg tablet F09396
Halobetasol propionate DM3GB6S Inflammation [1A00-CA43.1] Halobetasol Propionate 0.01% lotion F23767
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia [2A20.0] Hydroxyurea 500 mg capsule F09899
Ibuprofen DM8VCBE Pain [MG30-MG3Z] Ibuprofen 200 mg tablet F10228
Imipramine DM2NUH3 Depression [6A70-6A7Z] Imipramine 100 mg capsule F10552
Isotretinoin DM4QTBN Acne vulgaris [ED80] Isotretinoin 10 mg capsule F10858
Labetalol DMK8U72 Hypertension [BA00-BA04] Labetalol Hydrochloride 5mg/ml injectable F23470
Larotrectinib DM26CQR Solid tumour/cancer [2A00-2F9Z] Larotrectinib 20 mg/ml solution F24272
Loxapine DM8AI9U Schizophrenia [6A20] Loxapine 10 mg capsule F12660
Luliconazole DMT73J8 Tinea pedis [1F28.2] Luliconazole 1% cream F23217
Methylergonovine DMBEX4O Spontaneous abortion [JA00.0] Methylergonovine 0.2 mg tablet F13519
Mirabegron DMS1GYT Overactive bladder [GC50.0] Mirabegron 8mg/ml extended release for suspension F23820
Nifedipine DMSVOZT Angina pectoris [BA40] Nifedipine 20 mg capsule F15252
Nortriptyline DM4KDYJ Depression [6A70-6A7Z] Nortriptyline 10 mg capsule F15511
Oxazepam DMXNZM4 Anxiety disorder [6B00-6B0Z] Oxazepam 30 mg capsule F16101
Oxymetazoline DM8ZXT6 Eye inflammation [9A02] Oxymetazoline 1% cream F23856
Oxymorphone DM65AGJ Pain [MG30-MG3Z] Oxymorphone 20 mg tablet F16416
Permethrin DMZ0Q1G Sarcoptes scabiei infection [1G04] Permethrin 1% lotion F23867
Phenytoin DMNOKBV Epilepsy [8A60-8A68] Phenytoin 100 mg capsule F17220
Procaine DM4LSNE Anaesthesia [9A78.6] Procaine 300000 units/ml injectable F24383
Procarbazine DMIK367 Hodgkin lymphoma [2B30] Procarbazine 50 mg capsule F17912
Sulfacetamide DMZ6VEY Acne vulgaris [ED80] Sulfacetamide 10% solution F23908
Sulfanilamide DMABVE9 Bacterial infection [1A00-1C4Z] Sulfanilamide 15% cream F23294
Temazepam DM02A65 Insomnia [7A00-7A0Z] Temazepam 15 mg capsule F20761
Temozolomide DMKECZD Grade IV astrocytoma [2A00.0] Temozolomide 180 mg capsule F20846
Tetracaine DM9J6C2 Spinal anesthesia [MB40.3] Tetracaine 1% cream F23306
Tetracycline DMZA017 Bacterial infection [1A00-1C4Z] Tetracycline 250 mg capsule F21016
Trimipramine DM1SC8M Major depressive disorder [6A70.3] Trimipramine 50 mg capsule F21721
Valproate DMCFE9I Epilepsy [8A60-8A68] Valproic acid 250 mg capsule F22012
Verapamil DMA7PEW Hypertension [BA00-BA04] Verapamil 240 mg capsule F22403
------------------
⏷ Show the Full List of 62 Approved Drug(s)
1 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
PHN-131 DM1SV8I Pain [MG30-MG3Z] Nalbuphine Hydrochloride 10mg/ml injectable F23236
------------------
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Discovery agent [N.A.] Oxybutynin 5mg/5ml Syrup F23501
------------------